Yilong Pharmaceutical Co., Ltd. in Luoyang of Henan Province, as one of the affiliated companies in Yilong Investment (Group) Company holding subsidiaries, it was founded in June 2003 in the former Zhongzhou pharmaceutical factory of Henan Province bankruptcy restructuring on the basis of the establishment of registered capital 26 million Yuan, owns the total assets of 120 million yuan, 416 staff, of whom 156 IT staff, with erythromycin thiocyanate meleumycinum, mushrooms of polysaccharides and so forth 9 kinds of raw materials, meleumycinum, polysaccharides of mushrooms and so on 34 varieties of preparation, amounts to 64 traditional medicine and Western medicine production license documents. The company belongs to biochemistry manufacturing pharmaceuticals, with an annual output of 1,000 tons of raw materials antibiotic fermentation capacity, 1.2 billion tablets (grains) agent production capability. Its dominant products, raw materials such as erythromycin thiocyanate and mushrooms of polysaccharide and so on, sold in more than 10 provinces and cities nationwide.
¡¡
¡¡¡¡To meet the national pharmaceutical industry GMP certification requirements,and to improve the quality of products and market competitiveness, the company has built a new plant GMP certification expansion project in Yichuan County Economic Development Zone . Under the project,it planned to invest 120 million yuan , cover200 mu, complete with a solid preparation production line for annual output of 1.2 billion tablets(grains), two production lines for fermentation raw materials, one production line for traditional medicine extraction and one production line of a proprietary Chinese medicine, and supply systems for water, electricity, gas, steam power and storages . With an annual output of 500 tons of various materials and 1.2 billion tablets(grains) of solid preparation,it has attained 200 million yuan in added value each year , made profit of 36 million yuan. Up to now production lines have been put into operation. Its main products are Victoria enzyme, the enzyme milk, meleumycinum, Armillarisin A in mushrooms of polysaccharides and so forth.Its products possess high quality, effective curative effect, and have reasonable prices.Therefore its products are sold quite well in middle and western regions¡¯markets, and won a praise by the users.
¡¡¡¡Currently, the company mapped out a five-year plan to accelerate its development by means of the implementation of creativing new varieties , marketing-led, branding, pioneering the development of strategic policy and constantly enhance their core competitiveness, and increase market share, further the pace of development, enlarge and strengthen their medical industry. It plans to reach the annual sales income of 10 billion yuan in 2010 ,become a larger base of biochemistry medicine, and set up a well-known "Yilong" medicine brand in China and foreign countries,and make greater contribution for the development of Chinese pharmaceutical industry .
